Study of the Risk of PREMaturité According to the Balance of Bacterial Flora VAginale
PREMEVA2
3 other identifiers
observational
1,000
1 country
1
Brief Summary
Objective To compare vaginal microbiota in the first trimester of pregnancy between spontaneous preterm and term deliveries
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 1, 2018
CompletedFirst Posted
Study publicly available on registry
August 7, 2018
CompletedAugust 7, 2018
August 1, 2018
1.6 years
August 1, 2018
August 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vaginal Microbiota pattern
All microorganism potentially present in the vagina
10 years
Secondary Outcomes (1)
Vaginal biological pattern
10 years
Study Arms (2)
Cases. Preterm Births
Microbiological and biological patterns on vaginal samples in the first trimester of pregnancy among spontaneous preterm births between 22 and 36 weeks
Controls. Term Births
Microbiological and biological patterns on vaginal samples in the first trimester of pregnancy among deliveries over ≥ 37 weeks
Interventions
To compare the microbiological and biological patterns between groups
Eligibility Criteria
Cohort of pregnant patients in the first trimester
You may qualify if:
- case: spontaneous preterm births between 22 and 36 weeks in one of the 14 centers
- controls : the following delivery over ≥ 37 weeks in the same center
You may not qualify if:
- Multiple pregnancies, medical interruptions of pregnancy and deaths in utero
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Lillelead
- Ministry of Health, Francecollaborator
Study Sites (1)
Hôpital Jeanne de Flandres, CHRU
Lille, France
Biospecimen
Vaginal samples with DNA of microorganisms
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Damien Subtil, MD,PhD
University Hospital, Lille
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2018
First Posted
August 7, 2018
Study Start
November 1, 2011
Primary Completion
June 1, 2013
Study Completion
December 1, 2014
Last Updated
August 7, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share